You are here

migraine

FDA expands Qulipta indication to include chronic migraine prevention

Healio

Tue, 04/18/23 - 10:13 pm

AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data

Endpoints

Thu, 07/30/20 - 10:56 am

Satsuma Pharmaceuticals Files for $80 Million IPO

CP Wire

Thu, 09/12/19 - 10:25 am

Satsuma Pharmaceuticals

Satsuma Pharmaceuticals Files for $80 Million IPO

Thu, 09/12/19 - 09:33 am

Satsuma Pharmaceuticals

Teva Confirms September PDUFA Date for Fremanezumab

CP Wire

Wed, 05/23/18 - 09:47 am

episodic migraines

Teva Confirms September PDUFA Date for Fremanezumab

Wed, 05/23/18 - 09:17 am

episodic migraines

New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine

Tue, 04/24/18 - 11:52 pm

Alder BioPharmaceutical

Large and Small: Here’s What’s Moving Eli Lilly and Zosano

Yahoo/Market Exclusive

Tue, 02/27/18 - 09:48 am

advanced breast cancer

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study

Streetwise Report

Wed, 02/25/15 - 10:16 am

Teva Pharmaceuticals

4 Key Drug Approvals Expected In The Next 30 Days

investors.com

Sat, 03/16/13 - 10:55 am

multiple sclerosis

United Therapeutics

type 2 diabetes

Allergan drops $958M on migraine drug maker MAP Pharma

Mass Device

Wed, 01/23/13 - 09:24 pm

NuPathe Wins U.S. FDA Approval for Migraine Skin Patch

Bloomberg

Sat, 01/19/13 - 12:07 pm

St. Jude builds case for neurostim migraine treatment

Wed, 10/3/12 - 10:48 pm

St. Jude Medical

St. Jude Medical Receives European CE Mark Approval of Eon Mini Neurostimulator, the World’s Smallest Rechargeable Device to Treat Chronic Migraine

Thu, 09/20/12 - 10:51 pm

St. Jude Medical